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Type 1 diabetes mellitus (T1DM) develops in genetically
predisposed people as a result of the destruction of the 
pancreatic beta cells caused by an autoimmune insulitis
(1,2,3). At present, the incidence of T1DM is on the
increase, while its age of onset decreases (4,5,6). Another
worldwide trend noted in recent years is an increase in 
use of complementary and alternative medicine (CAM).
According to the National Institute of Health (USA), CAM is
a wide health area which is outside the politically dominant
health system in a society or culture in a specific time 
interval and  includes health services, applications, methods,
and their accompanying beliefs and theories (7).
Also in Turkey, the use of CAM is increasing in both
adults and children. We observed that many individuals 
suffering from any kind of ailment tend to try various herbs,
vitamins, antioxidant agents, yoga, meditation, bioenergy,
acupuncture, aroma therapy and prayers in an effort to find
a cure for their condition.
The studies about the use of CAM in T1DM children are
scarce. The objective of this study was to detect the methods
and frequency of use of CAM in T1DM children and to compare
those children with a group of controls with regard to variables
such as age, sex, insulin requirement, presence of diabetic 
complications, and sociocultural/ socioeconomic background.
The study also aimed to explore the expectations of the families
that motivated them to use these treatments.
ABSTRACT
Objective: Complementary and alternative medicine (CAM) is 
increasingly utilized in adults and children for treatment of various 
conditions. Studies on CAM in diabetes have mainly focused on the
adult population and its application in children has not been well 
established. The aim of this study was to examine the prevalence and
characteristics of CAM use in Turkish children with type 1 diabetes 
mellitus (T1DM).   
Methods: The information was acquired by a questionnaire completed
by a face-to-face interview with the parents of children with T1DM. 
Results: A total of 195 subjects (mean age: 14.02±4.7 years; F/M:
103/92) were included in this survey. Use of CAM was reported in 85
subjects (43.6%).  Herbal medicines were used in 64 subjects (75.3%).
Sixty-nine subjects (81.2%) did not inform the diabetes specialist about
CAM use. Thirty-eight subjects (44.7%) evaluated CAM as efficacious.
Only 3 subjects (3.5%) interrupted the insulin injections to use CAM. No
relationships were found  between CAM use and parental education or
insulin dose. There were significant correlations between CAM use and
higher family income (p=0.027), urban residence (p=0.05), presence of
complications (p=0.03), dissatisfaction with medical therapy (p=0.034)
and prior CAM use among parents (p=0.001). 
Conclusion: CAM use is a frequent practice among diabetic children,
which is usually not shared with their physicians  and sometimes leads
to cessation of medical treatment. 
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R Re ec ce ei iv ve ed d: : 17.02.2011 A Ac cc ce ep pt te ed d: : 21.06.2011Materials and Methods 
The study was conducted on 200 T1DM patients under
the age of 21 who were being followed in the Pediatric
Endocrinology Department of Goztepe Education and
Research Hospital.
Before the research, an approval was obtained from the
Ethics Committee of Goztepe Education and Research Hospital,
as per their decision number 55/B, dated March 10, 2009.
The families of the diabetic patients were given 
information on the aims of the study and they were also
told that they were free to leave the study at any time and
to refrain from answering some of the questions.  CAM
was defined as any treatment of a disease which is not
included in the biomedical context.
After written informed consent for interviewing and
completing the questionnaire forms was obtained from 
the patients’ parents, a questionnaire entitled “Use of 
alternative medicine in T1DM patients” was filled out by
interviewing each family face to face. 
Five patients, whose questionnaire forms had been
completed fully, were excluded from the study for being
unable to answer the questions clearly.  
The questionnaire included questions on demographic
data (age, education level, socioeconomic status, place of
residence), on frequency of use of CAM, method used,
how it was used, reason for resorting to CAM, source of
information on CAM, time of its initiation, association
between CAM use and occurrence of complications, as
well as questions on parents’ satisfaction with the medical
treatment their children were receiving. 
T1DM patients who were using CAM and those 
who were not were compared with respect to the above-
mentioned data.  
NCSS 2007& PASS 2008 Statistical Software (Utah,
USA) program was used for the statistical analysis. During
the assessment of the data of the study, besides the
descriptive statistical methods (mean, standard deviation,
frequency), the Student’s t-test was used for the 
comparison of the quantitative data and normally 
distributed parameters between the groups. Chi-square
test and Fisher’s exact chi-square test were applied for the
comparison of the qualitative data. The confidence interval
of the results was 95% and the level of significance was
taken as a p-value of less than 0.05. 
Results
The mean age of the patients (103F, 92M) was 14.0±4.7
years. 89.2% (n=174) of the mothers were 
housewives and 76.4% (n=149) had attended school for at
least five years.  52.3% (n=102) of the fathers were
workers and 68.2% (n=133) had attended school for at least
five years. 48.2% (n=94) of the families had a monthly
income between $611.62 and $1.223.24. 89.2% (n=174)
were living in big cities. While no complications related to the
diabetic state were reported in 90.8% (n=177) of the
patients, 2.6% (n=5) had a concomitant chronic disease such
as coeliac disease and autoimmune thyroiditis.  4.6% (n=9)
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Special diet 2 2.4
Acupuncture 2 2.4
Bioenergy 1 1.2
Colon hydrotherapy  1 1.2
Total 85 100
CAM: complementary and alternative medicine
Table 2. The distribution of herbal CAMs        
n%
Stinging nettle 13 20.3
Cinnamon 13 20.3
Thyme juice 16 25
Black cumin 7 10.9
Linseed 3 4.7
Pomegranate 6 9.4
Rose hip 3 4.7
Aloe vera 8 12.5
Black fruit herbal 3 4.7
Parsley juice 3 4.7




CAM: complementary and alternative medicineof the parents expressed that they were not satisfied with
the medical treatment their children were receiving and
29.7% (n=57) of the parents stated that they had used alter-
native treatment for themselves previously. 
43.6% (n=85) of the parents had given alternative 
treatment besides the medical treatment to their children,
while the remaining 56.4% (n=110) had not. However, 71.3%
(n=139) of the parents commented  that they would use
these treatments if their children had a malignant condition.
Herbal compounds, in particular thyme juice, cinnamon, 
stinging nettle, aloe vera, were the most frequently 
mentioned substances used as CAM  (Tables 1 and 2).
64.7% (n=55) of the parents stated that they applied CAM
as a complementary method  supporting the medical 
treatment. 30.6% (n=26) reported that they got the 
information from their friends and 29.4% (n=25) - from their
families and close relatives. 31.8% (n=27) of the patients had
begun to use CAM within 3 months of the onset of the 
disease. 30.6% (n=26) stated that they had been using CAM
for more than one year. Initiation of medical treatment was
found to be delayed in 3.5% (n=3) of the patients 
and 81.2% (n=69) of the parents did not share with their 
doctors that they were using CAM methods. 44.7% (n=38) of
the parents found CAM to be beneficial and 51.8% (n=44) 
recommended these methods to others. 48.2% (n=41) of the
parents who used CAM were still using the alternative 
treatments at the time the questionnaire forms were filled out. 
Although no statistically significant association was found
between use of alternative treatment in children and 
education level of parents, the rate of CAM use in big cities
was markedly higher than that in small towns (p<0.05). It was
also seen that as the level of income increased, the use of
CAM in children increased (p=0.027) (Table 3). The use of
alternative treatment was found to be significantly higher in
children with diabetic complications or accompanying 
autoimmune disease as compared to those with no 
complications (p=0.030). The rate of CAM use was found to
be considerably greater in children whose parents were not
satisfied with the medical treatment and in children whose
parents had previously used alternative treatment for 
themselves than in those who were satisfied and those who
had no experience of CAM (p<0.01 and  p<0.01, respectively).   
Discussion
According to previous studies conducted in Canada,
Australia, Denmark and Turkey,  nearly half of parents
(8,9,10,16)  and, to studies conducted in USA and New
Zealand, approximately 20-40% of parents (11,12,13,14,15)
reported using one CAM method sometime in their lives. 
The number of studies on use of CAM in T1DM patients
is limited. Miller et al (17) and Dannemann et al (18) reported
that the frequency of CAM use in children with T1DM was
19% in the USA and 18.4% in Germany. Even though the
rate in our study was found to be  relatively higher than that 
estimated in other countries, this rate was compatible with
the results of studies conducted in the general population
and in children with chronic disease (16,19), as well as in
children with T1DM (36) in Turkey. The high rate of CAM
use in our patients may be due to the chronic nature of the
disease, its labile course and the complexity of the medical
treatments, which may have been the factors that led these
parents to search for new ways of treatment to achieve
better control (20,21).
In our study, the most frequently mentioned CAM
method was administration of herbs. This finding was 
consistent with the results of some of the studies reported
from the USA (12,14) and of many studies from Turkey and
other  countries (16,19,22,23,24,25,26,27). Dannemann et al
(18) found that herbs, homeopathy and vitamins were the
most commonly applied CAM methods, while Miller et al (17)
noted in their study that religious practices, use of herbs and
vitamins were the most frequent ones. In our country, Arikan
et al (36) reported that herbs were the most commonly used
CAM method (59.6%), a finding also compatible with our
results. Only 4 patients in our study had used homeopathy,
naturopathy, or chiropraxy, which are methods more popular
in other countries. The high cost of these practices may be
the reason why they are not so preferred in Turkey. 
As to the type of herb used, Dannemann et al (18)
reported that cinnamon and aloe vera were the most 
commonly used  ones, while Arikan et al (36) found that
aloe vera, stinging nettle and mulberry were the herbs most
frequently given to children with T1DM. In our study, the
most commonly administered types were thyme juice,
stinging nettle, cinnamon and aloe vera. Others have also
reported that cinnamon and aloe vera are especially popular
for the treatment of DM (29,30,31). 
Although many studies showed that the use of 
CAM was directly proportional to the education level of the
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Table 3. Demographic characteristics          
Use of CAM 
Yes No p 
n (%) n (%)
Mother’s level  Low** 69 (42.1) 95 (57.9) χ2:0.965 
of education High***  16 (51.6) 15 (48.4) p=0.326
Father’s level  Low 59 (44.4) 74 (55.6) χ2:0.101
of education High 26 (41.9) 36 (58.1) p=0.750
Place of  Urban 80 (46.0) 94 (54.0) χ2:3.745 
residence Rural 5 (23.8) 16 (76.2) p=0.050
Economic status >1223  5 (45.5) 6 (54.5)
(US dollars/ 611-1223 33 (60.0) 22 (40.0) χ2:9.215
month) 306-612 36 (38.3) 58 (61.7) p=0.027*
< 306 11 (31.4) 24 (68.6)
* p<0.05, ** < 5 years, *** > 5 years
CAM: complementary and alternative medicinemothers (14,16,18,28) and the level of income of the 
family (8,9,18), Pitetti et al (11) and Miller et al (17) did not
find that these factors had a significant effect. In contrast,
Arikan  et al (36) observed that the use of CAM decreased
as the education level of the mother and the socioeconom-
ic status of the family increased. It was also reported that
the use of CAM by the parents themselves was a factor
which increased the rate of use of CAM in their children
(16,17,32,33). In our study, the use of CAM by the parents
themselves was found to be directly proportional to the use
of CAM in their children. Although we did not detect any
correlation between CAM use and education level of the
parents, the use of CAM was found to be significantly 
higher in families having a high level of income and living in
the big cities, a finding consistent with previous studies.
We also found that when the parents were asked about
using CAM if their children had cancer, the rate of use of
CAM would increase from 43.6% to 71.3%.  This 
result may be indicative of the parents’ view about DM as
a treatable disease, even if it takes a lifetime. The risk of
most complications of DM decreases with an adequate
treatment, while cancer is perceived as a much more 
mortal disease by the families. 
The use of CAM was found to be significantly higher in
patients with complications and in those with concomitant
diseases. This finding may be due to increased anxiety 
in the parents when faced with a complication or an 
accompanying disease.
In our study, religious beliefs were found to be 
important factors encouraging the family  to use alternative
treatment methods that were mostly applied to support the
medical treatment. In our series, there were only 3 families
who quit the medical treatment to use CAM. Dannemann
et al (18) reported that the most commonly expressed 
reasons for using CAM was “to try everything” and “their
having fewer side effects”.
As to source of information about CAM, we found that
the majority of the parents had learnt about CAM from their
friends and relatives. This finding is compatible with the
results of similar studies in our country, while the  media
and internet are reported as the most common sources of
information about the CAM methods in Western countries
(16,34, 35). In our study, a few patients got the information
from their doctors, but only 18.8% of the families shared
this with their doctors. Ozturk et al (16) and Arikan et al (36)
reported  similar results, while the rate estimated by
Dannemann et al (18),  for sharing the information on use of
CAM with their doctors, was much  higher. Also in
Dannemann’s study, the parents stated that only 37.3% of
the doctors advised their patients to leave the alternative
treatment. The patients who did not tell their doctors about
the use of CAM commented that their reason for not telling
was that their doctors would not understand (18). 
In this present study, when the parents were asked
their opinion on the use of CAM, half of them said that they
found them beneficial. This ratio was reported as 71.7% by
Ozturk et al (16), as  53.8% by Arikan et al (36), and as
62.5% by  Dannemann et al (18). In all these studies, the
issue of usefulness was evaluated by discourse with the
families, i.e. subjectively, and was not based on objective
criteria such as a decrease in the dosage of insulin or level
of HbA1c. 
Our study indicates that, similar to its practice in other
chronic diseases, CAM is frequently used in children with
T1DM.  As also shown in other studies from Turkey, herbs
are the most commonly administered substances in our
country. It also appears that when problems occur in the
course of the disease, the rate of use of these substances
increases. Studies are needed to determine their efficacy,
safety, as well as the potential herb-drug or vitamin-drug
interactions and to examine the side effects that can occur
due to these interactions. In conclusion, pediatricians
should communicate with the patients about the CAM
methods and inform them about their benefits, harms and
possible contraindications.
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